Monica Joanna Elnekaveh's advocacy began when Eleanor was initially diagnosed with two mosaic gaba receptor gene deletions (GABRA1 and GABRG2). Driven by the urgent need for treatments, Monica founded ...
Under this partnership, Grann will lead proof-of-concept and preclinical animal studies targeting GABAAR variants, applying the same innovative therapeutic platform and scientific rigor that made the ...
Researchers from the Centre for Addiction and Mental Health (CAMH) and affiliated organizations presented preclinical data for the α5-GABA-A receptor (α5-GABAAR) positive allosteric modulator GL-II-73 ...
Damona Pharmaceuticals Inc. has obtained IND clearance from the FDA for DPX-101 for the treatment of cognitive deficits in brain disorders, including major depressive disorder. The company plans to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results